It is found to promote HIF-1α (Hypoxia-inducible factor-1α) to inhibit the expression of VEGF in breast cancer cells substantially and also interacted with VEGF receptor-2 (VEGFR-2) to block its kinase action (Table 3) (Wang et al., 2013). This evidence concerns the gene HIF1A and breast carcinoma.